Neuren is a drug company. It is relatively serious (and boring) stuff, so I've got no problems with that presentation. I actually found it easier to read and pick the important info out than previous.
I am still concerned with the only 58% continuation rate of Daybue. It limits our max royalty $ quite a lot, but 2591 is still the drug to follow for the future.
Neuren is a drug company. It is relatively serious (and boring)...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.61 |
Change
0.140(1.12%) |
Mkt cap ! $1.611B | |||
| Open | High | Low | Value | Volume |
| $12.45 | $12.62 | $12.22 | $2.973M | 237.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1257 | $12.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.62 | 1257 | 1 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |